Cardiome Pharma Corp. (T:COM)

Business Focus: Biopharmaceuticals

This company is also listed in the United States as CRME on the NASDAQ. Click here to see if there are any SEC insider filings on
Log in or sign up for a free account to add this stock to your watch list.
Show only public market trades

Insider Chart - Past 6 Months

Insider Filings

Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by transaction date) for COM within the last 6 months ?
Amended Filing
As of 11:59pm ET May 25th, 2016
Insider Name Ownership
Securities Nature of transaction Volume or Value Price
Mar 24/16 Mar 24/16 Grant, Sheila Direct Ownership Options 52 - Expiration of options -5,000 $24.70